[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 66, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 3007214, "exercisedValue": 0, "unexercisedValue": 1401880}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 62, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3327225, "exercisedValue": 0, "unexercisedValue": 7193319}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 58, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3174030, "exercisedValue": 0, "unexercisedValue": 4835902}, {"maxAge": 1, "name": "Dr. James E. Bradner M.D.", "age": 53, "title": "Executive Vice President of Research & Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 4095677, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 57, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 50, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Casey  Capparelli", "title": "Executive Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan P. Graham J.D.", "age": 64, "title": "Executive VP, General Counsel & Secretary", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 2440307, "exercisedValue": 0, "unexercisedValue": 2105468}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 330.11, "open": 328.97, "dayLow": 323.89, "dayHigh": 332.075, "regularMarketPreviousClose": 330.11, "regularMarketOpen": 328.97, "regularMarketDayLow": 323.89, "regularMarketDayHigh": 332.075, "dividendRate": 9.66, "dividendYield": 2.96, "exDividendDate": 1770940800, "payoutRatio": 0.72620004, "fiveYearAvgDividendYield": 3.07, "beta": 0.45, "trailingPE": 25.181469, "forwardPE": 14.850376, "volume": 2117311, "regularMarketVolume": 2117311, "averageVolume": 2702690, "averageVolume10days": 1940990, "averageDailyVolume10Day": 1940990, "bid": 327.43, "ask": 328.05, "bidSize": 1, "askSize": 1, "marketCap": 175598534656, "fiftyTwoWeekLow": 261.28, "fiftyTwoWeekHigh": 346.38, "allTimeHigh": 346.85, "allTimeLow": 0.075521, "priceToSalesTrailing12Months": 4.88167, "fiftyDayAverage": 326.6732, "twoHundredDayAverage": 298.0682, "trailingAnnualDividendRate": 9.39, "trailingAnnualDividendYield": 0.028445067, "currency": "USD", "tradeable": false, "enterpriseValue": 220750774272, "profitMargins": 0.19474001, "floatShares": 537129085, "sharesOutstanding": 538480671, "sharesShort": 14121914, "sharesShortPriorMonth": 13363223, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.026199998, "heldPercentInsiders": 0.00212, "heldPercentInstitutions": 0.83974, "shortRatio": 4.87, "shortPercentOfFloat": 0.026300002, "impliedSharesOutstanding": 538480671, "bookValue": 17.863, "priceToBook": 18.255611, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 0.136, "netIncomeToCommon": 7005000192, "trailingEps": 12.95, "forwardEps": 21.95904, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.137, "enterpriseToEbitda": 13.394, "52WeekChange": 0.22176981, "SandP52WeekChange": 0.18594909, "lastDividendValue": 2.38, "lastDividendDate": 1763683200, "quoteType": "EQUITY", "currentPrice": 326.1, "targetHighPrice": 425.0, "targetLowPrice": 180.0, "targetMeanPrice": 330.4074, "targetMedianPrice": 333.0, "recommendationMean": 2.40625, "recommendationKey": "buy", "numberOfAnalystOpinions": 27, "totalCash": 9445000192, "totalCashPerShare": 17.54, "ebitda": 16481000448, "totalDebt": 54586998784, "quickRatio": 0.823, "currentRatio": 1.28, "totalRevenue": 35970998272, "debtToEquity": 567.491, "revenuePerShare": 66.892, "returnOnAssets": 0.07706, "returnOnEquity": 0.8171, "grossProfits": 25198000128, "freeCashflow": 11408624640, "operatingCashflow": 13125999616, "earningsGrowth": 0.136, "revenueGrowth": 0.124, "grossMargins": 0.70051, "ebitdaMargins": 0.45817003, "operatingMargins": 0.34153, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "postMarketChangePercent": 0.122659884, "postMarketPrice": 326.5, "postMarketChange": 0.3999939, "regularMarketChange": -4.00998, "regularMarketDayRange": "323.89 - 332.075", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2702690, "fiftyTwoWeekLowChange": 64.82001, "fiftyTwoWeekLowChangePercent": 0.24808638, "fiftyTwoWeekRange": "261.28 - 346.38", "fiftyTwoWeekHighChange": -20.279999, "fiftyTwoWeekHighChangePercent": -0.05854841, "fiftyTwoWeekChangePercent": 22.176981, "dividendDate": 1772755200, "earningsTimestamp": 1762290000, "earningsTimestampStart": 1762290000, "regularMarketChangePercent": -1.21474, "regularMarketPrice": 326.1, "corporateActions": [], "postMarketTime": 1768006513, "regularMarketTime": 1767992400, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "earningsTimestampEnd": 1762290000, "earningsCallTimestampStart": 1762291800, "earningsCallTimestampEnd": 1762291800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 12.95, "epsForward": 21.95904, "epsCurrentYear": 21.27054, "priceEpsCurrentYear": 15.331063, "fiftyDayAverageChange": -0.57318115, "fiftyDayAverageChangePercent": -0.0017546011, "twoHundredDayAverageChange": 28.0318, "twoHundredDayAverageChangePercent": 0.09404492, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "displayName": "Amgen", "trailingPegRatio": 1.0378, "__fetch_time": "2026-01-10"}]